Our Board

Jo is an experienced and successful investment professional with more than 10 years in the private equity industry. A qualified accountant, ACA, by training, she has worked in the corporate finance departments of FTSE 100 and FTSE 250 companies.

Dr Jim Smith is Interim Director of the Babraham Institute. Jim brings deep experience in research leadership and translational science, helping to ensure the Campus remains closely connected to cutting edge biology and real world application.

Karen studied for a degree in biology and PhD in microbiology. Before joining BBSRC, she worked in commercial research and development with both a small biotechnology company and a large corporate.

Rich joined Babraham Research Campus in 2026 from LBIC (London Bioscience Innovation Centre Ltd).

Becky is Chief Financial Officer. Having joined Babraham Research Campus Ltd (formerly BBT) in 2002, Becky is responsible for the finance, HR and health & safety functions of Babraham Research Campus Ltd.

Clive is an independent cancer drug discovery and development advisor. In addition to the Babraham Research Campus, Clive holds non-executive director positions at Atelerix Ltd and CytoSeek Ltd and serves on the scientific advisory boards of 4Bio Capital and ANGLE plc.

Alex is a highly experienced Chartered Engineer and Chartered Surveyor with over 20 years’ experience working in a variety of environments successfully delivering business critical projects and programmes; the last 13 years of which have been specialising within the life-sciences sector.

Charlie is currently a Senior Strategic Advisor at Cambridge University Health Partners (CUHP), developing the funding pillar of the Life Sciences Strategy. He is also a Senior Advisor at Lazard, the world’s largest independent investment bank, having first joined Lazard as a Managing Director in December 2009, responsible for European Capital Markets Advisory.